<DOC>
	<DOCNO>NCT00159757</DOCNO>
	<brief_summary>There evidence ziprasidone efficacious decrease magnitude positive negative symptom schizophrenia , also effective treatment depressive symptom . It show good tolerance low incidence extrapyramidal side effect significantly influence body weight . As show ziprasidone efficacious safe patient pretreated antipsychotic withdrawn either due side effect satisfy efficacy . The purpose study provide evidence efficacy safety patient schizophrenia allow psychiatrist Hungary gain experience drug wide commercial availability .</brief_summary>
	<brief_title>12 Week Open , Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients</brief_title>
	<detailed_description>Study terminate due difficulty enrol targeted number patient March 1 , 2005 , last subject last visit date Feb.16 , 2005 . There safety concern involve decision terminate trial .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>confirm diagnosis schizophrenia accord DSMIVIV patient 's medical file subject current treatment typical atypical neuroleptic change patient significant cardiovascular illness ( recent acute myocardial infarction , uncompensated heart failure , cardiac arrhythmia ) patient ' history clinically significant ECG abnormality particularly prolongation QT interval 500 m</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>